These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3109993)

  • 1. Effect of workup strategy on the cost-effectiveness of fecal occult blood screening for colorectal cancer.
    Barry MJ; Mulley AG; Richter JM
    Gastroenterology; 1987 Aug; 93(2):301-10. PubMed ID: 3109993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of screening for colorectal cancer in Japan.
    Tsuji I; Fukao A; Shoji T; Kuwajima I; Sugawara N; Hisamichi S
    Tohoku J Exp Med; 1991 Aug; 164(4):269-78. PubMed ID: 1746016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The workup of the asymptomatic patient with a positive fecal occult blood test.
    Brandeau ML; Eddy DM
    Med Decis Making; 1987; 7(1):32-46. PubMed ID: 3100902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.
    Vijan S; Hwang EW; Hofer TP; Hayward RA
    Am J Med; 2001 Dec; 111(8):593-601. PubMed ID: 11755501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of costs and effects of screening for colorectal cancer in the United States.
    Byers T; Gorsky R
    Cancer; 1992 Sep; 70(5 Suppl):1288-95. PubMed ID: 1387342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for colorectal cancer: the cost to find an advanced adenoma.
    McGrath JS; Ponich TP; Gregor JC
    Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of colon cancer screening.
    Lieberman D
    Am J Gastroenterol; 1991 Dec; 86(12):1789-94. PubMed ID: 1962624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness model for colon cancer screening.
    Lieberman DA
    Gastroenterology; 1995 Dec; 109(6):1781-90. PubMed ID: 7498642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening flexible sigmoidoscopy by primary care physicians. Effectiveness and costs in patients negative for fecal occult blood.
    Rumans MC; Benner KG; Keeffe EB; Custis JM; Lockwood DR; Craner GE
    West J Med; 1986 Jun; 144(6):756-8. PubMed ID: 3088841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How good is screening for colorectal cancer?
    Nostrant TT; Wilson JA
    Postgrad Med; 1983 Jun; 73(6):131-9. PubMed ID: 6856522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.
    O'Leary BA; Olynyk JK; Neville AM; Platell CF
    J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of rectal bleeding in adults. A cost-effectiveness analysis comparing four diagnostic strategies.
    Allen E; Nicolaidis C; Helfand M
    J Gen Intern Med; 2005 Jan; 20(1):81-90. PubMed ID: 15693933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexible sigmoidoscopy plus air-contrast barium enema versus colonoscopy for evaluation of symptomatic patients without evidence of bleeding.
    Rex DK; Mark D; Clarke B; Lappas JC; Lehman GA
    Gastrointest Endosc; 1995 Aug; 42(2):132-8. PubMed ID: 7590048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness and projected national impact of colorectal cancer screening in France.
    Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
    Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening: new opportunities.
    Levin TR
    Surg Oncol Clin N Am; 1999 Oct; 8(4):673-91, vi-vii. PubMed ID: 10452934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial evaluation of rectal bleeding in young persons: a cost-effectiveness analysis.
    Lewis JD; Brown A; Localio AR; Schwartz JS
    Ann Intern Med; 2002 Jan; 136(2):99-110. PubMed ID: 11790061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost benefit of early diagnosis of colorectal cancer.
    Bolin TD
    Scand J Gastroenterol Suppl; 1996; 220():142-6. PubMed ID: 8898453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of colorectal cancer screening.
    McMahon PM; Bosch JL; Gleason S; Halpern EF; Lester JS; Gazelle GS
    Radiology; 2001 Apr; 219(1):44-50. PubMed ID: 11274533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.